Search

A study from Memorial Sloan Kettering found that young patients ages 18 to 39 with early-onset cancer have an especially high risk of harboring inherited genetic (germline) mutations.

… Monday, June 22, 2020 A study from Memorial Sloan Kettering (MSK) found that young patients ages 18 to 39 with early-onset cancer have an especially high risk of harboring inherited genetic (germline) mutations. Results from this study were presented by Zsofia K. Stadler, MD , medical oncologist at MSK

MSK researchers are rethinking the relationship between metabolism and cancer, and finding insights in some unexpected places. Your beer glass, for example.

… Tuesday, January 12, 2016 Summary Scientists have known for 100 years that cancer cells metabolize nutrients in a unique way, though they haven’t understood why. In a new paper, MSK researchers reconsider the evidence and offer an unorthodox explanation, turning some commonsense wisdom on its head. Highlights

Memorial Sloan Kettering Cancer Center (MSK) researchers presented results of their latest research at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition held in San Diego from December 7 to 10, 2024.

… Tuesday, December 10, 2024 Memorial Sloan Kettering Cancer Center (MSK) researchers presented results of their latest research at the 66 th American Society of Hematology (ASH) Annual Meeting and Exposition held in San Diego from December 7 to 10, 2024. Highlights of practice-changing insights for patients

MSK’s new Robert and Kate Niehaus Center for Inherited Cancer Genomics is using the latest in gene sequencing technologies to discover the inherited causes of cancer.

… Tuesday, December 8, 2015 Summary MSK’s new Robert and Kate Niehaus Center for Inherited Cancer Genomics is using the latest in gene sequencing technologies to discover the inherited causes of cancer. The ultimate goal is to develop new approaches for prevention as well as earlier detection and treatment

On World Cancer Day, MSK Launches Public-Service Announcement ‘Late,’ Emphasizing the Urgency and Power of Routine Cancer Screenings

… Monday, February 5, 2024 Today, Memorial Sloan Kettering Cancer Center (MSK), in collaboration with Miami-based creative agency Alma, launched a bilingual public service campaign to promote the importance of routine cancer screenings. As cancer is the leading cause of death among Hispanic individuals

Discover some of the most exciting research that Memorial Sloan Kettering scientists are pursuing in the fight against cancer.

… Tuesday, May 10, 2016 Summary Memorial Sloan Kettering scientists believe there are many reasons to be hopeful about the future of cancer care and research. Here, we take a look at five promising advances that are transforming the way we think about cancer and delivering new treatment tactics. Highlights

At Memorial Sloan Kettering, as the genetics revolution continues to flourish, discoveries made in the laboratory are increasingly producing real-world benefits for cancer patients.

… Wednesday, October 1, 2008 Summary At Memorial Sloan Kettering, as the genetics revolution continues to flourish, discoveries made in the laboratory are increasingly producing real-world benefits for cancer patients. As the genetics revolution continues to flourish, discoveries made in the laboratory

Memorial Sloan Kettering Cancer Center’s website has been nominated for The Webby Award, the most prestigious international award honoring excellence on the Internet. Selected from among nearly 10,000 total entries, the Center’s website is one of five nominated in the Health category.

… Thursday, April 12, 2012 Memorial Sloan Kettering Cancer Center’s website has been nominated for The Webby Award, the most prestigious international award honoring excellence on the Internet. Selected from among nearly 10,000 total entries, the Center’s website is one of five nominated in the Health

Research from the lab of cancer biologist Tuomas Tammela shows that some lung cancer cells retain a “memory” of the healthy cell where they came from — one that might be exploited to make an emerging type of lung cancer treatment called KRAS inhibition more effective.

… Friday, November 17, 2023 A new understanding of lung cancer cells’ “memories” suggests a new strategy for improving treatment, Memorial Sloan Kettering Cancer Center (MSK) researchers have found. Research from the lab of  cancer biologist Tuomas Tammela, MD, PhD shows that some lung cancer cells retain

New insights into the pathophysiology of lymphedema are providing targets for future treatment interventions to cure and prevent the disease, according to our recent research.

… Friday, June 7, 2019 New insights into the pathophysiology of lymphedema are providing targets for future treatment interventions to cure and prevent the disease, according to our recent research. Previously, it was believed that the lymphatic vasculature played a passive role by transporting antigen-presenting